Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms ND 032, ND-032 |
Target |
Mechanism CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), ROR1 antagonists(Inactive tyrosine-protein kinase transmembrane receptor ROR1 antagonists), Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | - |